Safety and Tolerability of Withania somnifera Root Extract in Healthy Male Participants: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
Abstract
ABSTRACT Withania somnifera (WS), also known as Ashwagandha in Ayurveda, is valued for its anti‐inflammatory, antioxidant, adaptogenic, and memory‐enhancing properties. This study assessed the safety of standardized Ashwagandha root extract in healthy adult participants over 180 days. A randomized, placebo‐controlled, double‐blind trial was conducted on 40 healthy adult participants (50–70 years), randomized 1:1 to receive 200 mg WS extract or placebo capsules twice daily for 180 days. Each WS capsule contained ≥ 5.00 mg of withanolides, standardized by HPLC‐PDA per USP‐NF monograph. Safety outcomes were assessed at screening and day 180. Hematological, hepatic, renal, and lipid profiles remained within normal ranges with no clinically significant changes compared to screening. Testosterone levels significantly increased (15.7%) in male participants in the WS group. Thyroid hormone levels, inflammatory marker (CRP), and NT‐pro BNP levels showed no adverse changes. CRP decreased by 51.1%, and NT‐pro BNP by 28.70% in the WS. Slight improvement in immunological markers (CD3, CD4, CD8) was also noted. The vital signs remained stable, with no clinical abnormalities detected on chest X‐ray or ECG. Anthropometric parameters were not clinically changed after treatment. Taken together, the study concluded that WS root extract capsules (200 mg twice daily for 6 months) were well‐tolerated and safe, with no adverse effects reported. This double‐blind, placebo‐controlled study with…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 40 participants or records.
Read the paper
Related studies
- Cortisol, obesity and the metabolic syndrome: A cross-sectional study of obese subjects and review of the literature
- Relationships between lead biomarkers and diurnal salivary cortisol indices in pregnant women from Mexico City: a cross-sectional study
- Pubertal Recalibration of Cortisol Reactivity Following Early Life Stress: A Cross-Sectional Analysis
- High-end normal adrenocorticotropic hormone and cortisol levels are associated with specific cardiovascular risk factors in pediatric obesity: a cross-sectional study
- Effects of remote virtual work environment during COVID-19 pandemic on technostress among Menoufia University Staff, Egypt: a cross-sectional study
- Low serum albumin, aspartate aminotransferase, and body mass are risk factors for frailty in elderly people with diabetes–a cross-sectional study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.